C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Explore this paper's citation graph
Summary
The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.
- Type
- article
- Published
- 2000-03-23
- Cited by
- 6,273
- References
- 28
- Access
- Open access
- OpenAlex
- https://openalex.org/W2058610272
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:2739420
Keywords
Medicine, Internal medicine, C-reactive protein, Serum amyloid A, Homocysteine
References
- Atherosclerosis is an Inflammatory Disease
- Baseline IgG Antibody Titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes Simplex Virus, and Cytomegalovirus and the Risk for Cardiovascular Disease in Women
- Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.
- Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.
- C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.
- Bee sting dysphagia.
- Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon.
- Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
- Homocysteine and risk of cardiovascular disease among postmenopausal women.
- Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.
- Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.
- Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events.
- C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.
- Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.
- Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
- Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
- Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.
- Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.
- Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Cited by
- Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.
- Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder.
- Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease
- BIOCHEMICAL MARKERS OF CORONARY HEART DISEASE
- Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
- Vitamin B6 and cardiovascular disease.
- The effect of subantimicrobial-dose-doxycycline periodontal therapy on serum biomarkers of systemic inflammation: a randomized, double-masked, placebo-controlled clinical trial
- Evaluation of cardiovascular disease markers in patients submitted to carotid artery stenting or endarterectomy
- The relationship between sleep-disordered breathing and high-sensitivity C-reactive protein in Japanese men.
- Malnutrition and Chronic Inflammation as Risk Factors for Cardiovascular Disease in Chronic Renal Failure
- Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.
- Early rheumatoid arthritis: a medical emergency?
- C-reactive protein--to screen or not to screen?
- Long-term combined supplementations with alpha-tocopherol and vitamin C have no detectable anti-inflammatory effects in healthy men.
- Effects of aspirin (325 mg/day) on serum high-sensitivity C-reactive protein, cytokines, and adhesion molecules in healthy volunteers.
- The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis.
- Local Generation of C-Reactive Protein in Diseased Coronary Artery Venous Bypass Grafts and Normal Vascular Tissue
- Editorial comment--C-reactive protein and vascular risk in stroke patients: potential use for the future.
- Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease.
- Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia
Related papers
- Proposal for Setting Guidance Levels on Entrance Surface Doses for Radiographic Examinations on Children in Japan
- Risk Prediction of High Sensitivity C-reactive Protein Level for Ischemic Stroke Events
- C-reactive Protein and Serum Amyloid A protein in Neonatal Infections
- Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times
- Comparative study of serum amyloid A protein and C-reactive protein in disease.
- [Variations of serum amyloid A protein and interleukin-6 in patients with low concentration of serum C-reactive protein].
- Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes.
- Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs.